---
document_datetime: 2025-11-13 17:03:47
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/mekinist-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: mekinist-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.5961601
conversion_datetime: 2025-12-28 01:56:55.645204
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Mekinist

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                       | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|-----------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation type IA / | A.ADMINISTRATIVECHANGES-A.7 | 13/11/2025                          |                                          | Annex II and                    |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000311204                       | Deletion of manufacturingsitesforan active substance, intermediate or finished product, packagingsite,manufacturerresponsiblefor batch release, site where batch control takes place,orsupplierofastartingmaterial, reagent or excipient (when mentioned in the dossier)* - Accepted                                                                                       |            |     | PL          |                                                                                                                                                                   |
|-----------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation typeIA_IN / EMA/VR/0000308071 | C.I.3 Change(s)in theSummary of Product Characteristics,Labelling orPackageLeaflet ofhumanmedicinalproductsintendedto implementtheoutcomeofaprocedure concermingPSURorPASS,ortheoutcomeof theassessmentdonebythecompetent authority under Articles 45 or 46 of Regulation1901/2006-C.1.3.z Implementation of wording agreed by the competent authority+QRDupdate- Accepted | 03/11/2025 |     | SmPC and PL | ToupdateSection4.8of theSmPCandSection4of thePLtoimplementthesignalrecommendationson 'Tattoo associatedskinreaction(EPITTno20160) adoptedatthe4September2025PRAC. |
| Variation type IB / EMA/VR/0000292059   | This was an application for a group off variations. B.II.d.2 Change in testprocedurefor the finished product-B.1I.d.2.d Other changes toa testprocedure(includingreplacement or addition)-Accepted B.II.d.2 Change in test procedure for the finished product-B.II.d.2.a Minor changes to an approved test procedure - Accepted                                            | 11/09/2025 | N/A |             |                                                                                                                                                                   |

<div style=\"page-break-after: always\"></div>

| B.1I.d.2 Change in test procedure for the finished product - B.II.d.2.a Minor changes to an approved test procedure - Accepted   |
|----------------------------------------------------------------------------------------------------------------------------------|